CELH
Celsius Holdings, Inc.
CELH has a slight edge over STZ overall, supported by stronger fundamentals and stronger modeled upside.
STZ
Constellation Brands, Inc.
STZ has lower modeled downside risk, despite its lower overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
STZ Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Healthy | |
| Under pressure |
STZ's profitability and cash flow are currently healthy, and its revenue is stable, but its balance sheet is under pressure.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
STZ PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $145 | — |
| Current | 13x | $145 | — |
| Cheap | 19x | $212 | +47% |
| Fair | 31x | $345 | +138% |
| Expensive | 62x | $686 | +374% |
Historical ranges are pointers, not guarantees.
STZ has the edge over CELH in the historical PE scenario, which offers more potential upside but is not a forecast.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over STZ on the outlook, with more favorable revenue expectations.
STZ Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect STZ's earnings to grow and its profitability to improve, with its revenue holding steady.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
STZ Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $11.90 | +6.8% |
| Q3 2026 | $11.15 | +63% |
| Q2 2026 | $10.48 | +$12.87 |
| Q1 2026 | $9.59 | +$10.08 |
| Q4 2025 | $6.34 | +70% |
| Q3 2025 | $6.85 | +120% |
| Q2 2025 | -$2.39 | -118% |
| Q1 2025 | -$0.49 | -105% |
| Q4 2024 | $3.74 | -56% |
STZ has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over STZ on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH's operating margin was 20% last quarter, up 31 points from the same quarter a year ago.
STZ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.6B | +6.1% |
| Q2 2026 | $2.4B | -3.3% |
| Q1 2026 | $1.9B | -11% |
| Q4 2025 | $2.2B | -9.8% |
| Q3 2025 | $2.5B | -15% |
| Q2 2025 | $2.5B | -5.5% |
| Q1 2025 | $2.2B | +1.2% |
| Q4 2024 | $2.5B | -0.3% |
STZ's revenue is down over the past year, though its latest quarter was up: $2.6B last quarter, up 6.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 31% | -4.7 points |
| Q2 2026 | 35% | +3 points |
| Q1 2026 | 26% | -15 points |
| Q4 2025 | 31% | -0.6 points |
| Q3 2025 | 35% | -2 points |
| Q2 2025 | 32% | -1.3 points |
| Q1 2025 | 40% | +11 points |
| Q4 2024 | 32% | -2.3 points |
STZ has the edge over CELH on profitability, with a higher operating margin.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
STZ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $639.9M | +0.8% |
| Q2 2026 | $484.6M | +9% |
| Q1 2026 | $343.9M | +10% |
| Q4 2025 | $370.9M | -19% |
| Q3 2025 | $634.8M | -26% |
| Q2 2025 | $444.4M | +41% |
| Q1 2025 | $312.1M | +311% |
| Q4 2024 | $456.8M | +16% |
STZ has the edge over CELH on cash flow, with more consistent year-over-year improvement.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has 255M diluted shares, down 1.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
STZ Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -1.8M shares |
| 1 year | -3% | -5.3M shares |
| 3 years | -7.4% | -13.7M shares |
| 5 years | -11% | -21.9M shares |
| Available history | -12% | -24.3M shares |
STZ has the edge over CELH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $230.9M |
| Q2 2026 | $223.8M |
| Q1 2026 | $100M |
| Q4 2025 | $220.1M |
| Q3 2025 | $297.9M |
| Q2 2025 | $306.1M |
| Q1 2025 | $455.7M |
| Q4 2024 | $218.9M |
STZ spent $775M buying back its own shares over the past year, down 39% from the year before.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has the edge over STZ on leverage, with a lower net debt burden relative to earnings.
STZ Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.2x | Elevated |
| Q2 2026 | 3.2x | Elevated |
| Q1 2026 | 3.5x | Elevated |
| Q4 2025 | 4.3x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 25.2x | High |
| Q1 2025 | 15.6x | High |
| Q4 2024 | 7.5x | High |
STZ's net debt is about 3.1 years of its operating earnings (EBITDA), down from 4.1 years a year ago.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
STZ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 84.2 | Overbought |
STZ's weekly RSI is 57 (neutral) and its Stochastic is 84 (overbought).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
STZ PE vs Consumer Defensive Sector
| Metric | STZ | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 19x | 33% below |
| PE % | 6 | 18 | 12 pts below |
STZ has the edge over CELH on valuation relative to its sector.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
STZ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $130.1 | 11% above |
| 20 week MA | $130.8 | 11% above |
| 50 week MA | $142.2 | 1.7% above |
| 100 week MA | $155.5 | 7% below |
| 200 week MA | $200.3 | 28% below |
STZ has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
STZ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $189.2 | $215.8 | +14% |
| 2021 | $215.8 | $244.0 | +13% |
| 2022 | $244.0 | $232.4 | -4.8% |
| 2023 | $232.4 | $241.8 | +4% |
| 2024 | $241.8 | $222.7 | -7.9% |
| 2025 | $222.7 | $139.4 | -37% |
| 2026 YTD | $139.4 | $144.6 | +3.7% |
STZ has the edge over CELH on returns for 2026, with the stronger performance.